111 – 120 of 397
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M).
- Contribution to journal › Article
-
Mark
Methods and Models for Metabolic Assessment in Mice
(2013) In Journal of Diabetes Research
- Contribution to journal › Article
-
Mark
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
- Contribution to journal › Article
-
Mark
Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.
- Contribution to journal › Article
-
Mark
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
- Contribution to journal › Article
-
Mark
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
(2013) Endokrindagarna, 2013
- Contribution to conference › Poster
- 2012
-
Mark
Varning för okritisk användning av överviktskirurgi vid typ 2-diabetes.
- Contribution to journal › Article
-
Mark
DPP-4 inhibition and islet function
- Contribution to journal › Scientific review
-
Mark
The hyperstimulated beta-cell: prelude to diabetes?
- Contribution to journal › Debate/Note/Editorial
